COPM
WINT

Charter Oak Partners Management’s Windtree Therapeutics Inc WINT Stock Holding History

Charter Oak Partners Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,739
Closed -$240K – 39
2013
Q3 		$240K Hold
8,739
– – 0.19% 33
2013
Q2 		$186K Buy
+8,739
New +$215K 0.15% 33

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charter Oak Partners Management's WINT Position: Q4 2013 in Review

Charter Oak Partners Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2013, closing a stake of 8,739 shares — an estimated $240K sold.

Charter Oak Partners Management first reported a position in WINT in Q2 2013 and held it in 2 quarters. The position peaked at $240K in Q3 2013. 60 funds tracked by Wall St. Rank hold WINT as of Q4 2013.

  • Charter Oak Partners Management reported no remaining Windtree Therapeutics Inc position as of Q4 2013 after selling out during the quarter.
  • Charter Oak Partners Management sold 8,739 Windtree Therapeutics Inc shares in Q4 2013, an estimated $240K.
  • Charter Oak Partners Management first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 2 quarters.
  • Charter Oak Partners Management's Windtree Therapeutics Inc position peaked at $240K in Q3 2013.
  • 60 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2013.

Based on Charter Oak Partners Management's 13F filing for Q4 2013, filed 13 Feb 2014.